A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Snap Stock Drops as Social Media Company Warns of Risk From Middle East War
'Reminds me of Mixer': Pokimane opens up about Twitch streamers moving platforms as she returns from hiatus
France says it thwarted attack on websites from Russian state-linked actors
Google explores AI tools for journalists, in talks with publishers -spokesperson
Alan Wake 2 Preview
The Best Graphics Cards for Compact PCs in 2023
Miles Morales Joins Fortnite: All Items, Price, How to Get
When is Warzone Caldera Shutting Down?
